These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22018620)
1. The cities study: conventional immunotherapy-investigating existing schedules. Baker TW; Webber CM; Tankersley MS Ann Allergy Asthma Immunol; 2011 Nov; 107(5):460-2. PubMed ID: 22018620 [No Abstract] [Full Text] [Related]
2. Shooting for a faster approach to the immunotherapy target: will cluster become conventional? Cox LS Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062 [No Abstract] [Full Text] [Related]
3. Fungal immunotherapy in patients with allergic fungal sinusitis. Greenhaw B; deShazo RD; Arnold J; Wright L Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615 [TBL] [Abstract][Full Text] [Related]
5. Some highlights of the first century of immunotherapy. Nelson HS Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612 [No Abstract] [Full Text] [Related]
6. Subcutaneous injection immunotherapy for optimal effectiveness. Nelson HS Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815 [TBL] [Abstract][Full Text] [Related]
7. Aspiration before immunotherapy injection is required. Geller M J Allergy Clin Immunol; 2007 Jul; 120(1):220-1; author reply 221. PubMed ID: 17418378 [No Abstract] [Full Text] [Related]
12. Monitoring the effect of allergen immunotherapy: a clinician's dream comes true? Bullens DM Clin Exp Allergy; 2010 Jul; 40(7):958-61. PubMed ID: 20642573 [No Abstract] [Full Text] [Related]
13. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy. Calabria CW; Coop CA; Tankersley MS J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075 [TBL] [Abstract][Full Text] [Related]
14. Functional regulatory T cells and allergen immunotherapy. Rolland JM; Gardner LM; O'Hehir RE Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):559-66. PubMed ID: 20859202 [TBL] [Abstract][Full Text] [Related]
15. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [TBL] [Abstract][Full Text] [Related]
16. Advantages and disadvantages of accelerated immunotherapy schedules. Cox L J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664 [No Abstract] [Full Text] [Related]
17. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. Cochard MM; Eigenmann PA J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352 [No Abstract] [Full Text] [Related]
18. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States. Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891 [No Abstract] [Full Text] [Related]